Rhapsido is part of the
BTK Inhibitors class and treats
Hives. BTK inhibitors are used to treat several types of cancer, including chronic lymphocytic
leukemia and mantle cell
lymphoma. Some are also used to treat conditions like
ITP and chronic spontaneous
urticaria. They work by blocking a protein called Bruton's tyrosine kinase (BTK), which helps certain cancer and immune cells grow and communicate. This helps slow cancer growth or reduce an overactive immune response. Rhapsido is only available as a brand name drug.